The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Non-opioid Pain Patch Market Research Report 2025

Global Non-opioid Pain Patch Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1562927

No of Pages : 105

Ask Your Query
Synopsis
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Non-opioid Pain Patch market was valued at US$ 631.4 million in 2023 and is anticipated to reach US$ 779.5 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
North American market for Non-opioid Pain Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-opioid Pain Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-opioid Pain Patch include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Patch.
Report Scope
The Non-opioid Pain Patch market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-opioid Pain Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Pain Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Segment by Type
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Segment by Application
OTC
Rx
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-opioid Pain Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Non-opioid Pain Patch Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Patch
1.2 Non-opioid Pain Patch Segment by Type
1.2.1 Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2030)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Indomethacin Patches
1.2.5 Counter-Irritant Patches
1.2.6 Fentanyl Patches
1.2.7 Others
1.3 Non-opioid Pain Patch Segment by Application
1.3.1 Global Non-opioid Pain Patch Market Value by Application: (2024-2030)
1.3.2 OTC
1.3.3 Rx
1.4 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patch Revenue 2019-2030
1.4.2 Global Non-opioid Pain Patch Sales 2019-2030
1.4.3 Global Non-opioid Pain Patch Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-opioid Pain Patch Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-opioid Pain Patch Average Price by Manufacturers (2019-2024)
2.4 Global Non-opioid Pain Patch Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application
2.7 Non-opioid Pain Patch Market Competitive Situation and Trends
2.7.1 Non-opioid Pain Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patch Players Market Share by Revenue
2.7.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Pain Patch Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Patch Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-opioid Pain Patch Global Non-opioid Pain Patch Sales by Region: 2019-2030
3.2.1 Global Non-opioid Pain Patch Sales by Region: 2019-2024
3.2.2 Global Non-opioid Pain Patch Sales by Region: 2025-2030
3.3 Global Non-opioid Pain Patch Global Non-opioid Pain Patch Revenue by Region: 2019-2030
3.3.1 Global Non-opioid Pain Patch Revenue by Region: 2019-2024
3.3.2 Global Non-opioid Pain Patch Revenue by Region: 2025-2030
3.4 North America Non-opioid Pain Patch Market Facts & Figures by Country
3.4.1 North America Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-opioid Pain Patch Sales by Country (2019-2030)
3.4.3 North America Non-opioid Pain Patch Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-opioid Pain Patch Market Facts & Figures by Country
3.5.1 Europe Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-opioid Pain Patch Sales by Country (2019-2030)
3.5.3 Europe Non-opioid Pain Patch Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-opioid Pain Patch Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-opioid Pain Patch Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-opioid Pain Patch Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-opioid Pain Patch Sales by Country (2019-2030)
3.7.3 Latin America Non-opioid Pain Patch Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-opioid Pain Patch Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-opioid Pain Patch Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-opioid Pain Patch Sales by Type (2019-2030)
4.1.1 Global Non-opioid Pain Patch Sales by Type (2019-2024)
4.1.2 Global Non-opioid Pain Patch Sales by Type (2025-2030)
4.1.3 Global Non-opioid Pain Patch Sales Market Share by Type (2019-2030)
4.2 Global Non-opioid Pain Patch Revenue by Type (2019-2030)
4.2.1 Global Non-opioid Pain Patch Revenue by Type (2019-2024)
4.2.2 Global Non-opioid Pain Patch Revenue by Type (2025-2030)
4.2.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2019-2030)
4.3 Global Non-opioid Pain Patch Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-opioid Pain Patch Sales by Application (2019-2030)
5.1.1 Global Non-opioid Pain Patch Sales by Application (2019-2024)
5.1.2 Global Non-opioid Pain Patch Sales by Application (2025-2030)
5.1.3 Global Non-opioid Pain Patch Sales Market Share by Application (2019-2030)
5.2 Global Non-opioid Pain Patch Revenue by Application (2019-2030)
5.2.1 Global Non-opioid Pain Patch Revenue by Application (2019-2024)
5.2.2 Global Non-opioid Pain Patch Revenue by Application (2025-2030)
5.2.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2019-2030)
5.3 Global Non-opioid Pain Patch Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Corporation Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Non-opioid Pain Patch Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Corporation Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actavis Non-opioid Pain Patch Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Lingrui
6.5.1 Lingrui Corporation Information
6.5.2 Lingrui Description and Business Overview
6.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lingrui Non-opioid Pain Patch Product Portfolio
6.5.5 Lingrui Recent Developments/Updates
6.6 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Corporation Information
6.6.2 Teikoku Seiyaku Description and Business Overview
6.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
6.6.5 Teikoku Seiyaku Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Non-opioid Pain Patch Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novartis Non-opioid Pain Patch Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Qizheng
6.9.1 Qizheng Corporation Information
6.9.2 Qizheng Description and Business Overview
6.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qizheng Non-opioid Pain Patch Product Portfolio
6.9.5 Qizheng Recent Developments/Updates
6.10 Endo
6.10.1 Endo Corporation Information
6.10.2 Endo Description and Business Overview
6.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Endo Non-opioid Pain Patch Product Portfolio
6.10.5 Endo Recent Developments/Updates
6.11 Huarun 999
6.11.1 Huarun 999 Corporation Information
6.11.2 Huarun 999 Non-opioid Pain Patch Description and Business Overview
6.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
6.11.5 Huarun 999 Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Non-opioid Pain Patch Description and Business Overview
6.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GSK Non-opioid Pain Patch Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Haw Par
6.13.1 Haw Par Corporation Information
6.13.2 Haw Par Non-opioid Pain Patch Description and Business Overview
6.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Haw Par Non-opioid Pain Patch Product Portfolio
6.13.5 Haw Par Recent Developments/Updates
6.14 Nichiban
6.14.1 Nichiban Corporation Information
6.14.2 Nichiban Non-opioid Pain Patch Description and Business Overview
6.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nichiban Non-opioid Pain Patch Product Portfolio
6.14.5 Nichiban Recent Developments/Updates
6.15 Mentholatum
6.15.1 Mentholatum Corporation Information
6.15.2 Mentholatum Non-opioid Pain Patch Description and Business Overview
6.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Mentholatum Non-opioid Pain Patch Product Portfolio
6.15.5 Mentholatum Recent Developments/Updates
6.16 Laboratoires Genevrier
6.16.1 Laboratoires Genevrier Corporation Information
6.16.2 Laboratoires Genevrier Non-opioid Pain Patch Description and Business Overview
6.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
6.16.5 Laboratoires Genevrier Recent Developments/Updates
6.17 BLUE-EMU
6.17.1 BLUE-EMU Corporation Information
6.17.2 BLUE-EMU Non-opioid Pain Patch Description and Business Overview
6.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)
6.17.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
6.17.5 BLUE-EMU Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Pain Patch Industry Chain Analysis
7.2 Non-opioid Pain Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Pain Patch Production Mode & Process
7.4 Non-opioid Pain Patch Sales and Marketing
7.4.1 Non-opioid Pain Patch Sales Channels
7.4.2 Non-opioid Pain Patch Distributors
7.5 Non-opioid Pain Patch Customers
8 Non-opioid Pain Patch Market Dynamics
8.1 Non-opioid Pain Patch Industry Trends
8.2 Non-opioid Pain Patch Market Drivers
8.3 Non-opioid Pain Patch Market Challenges
8.4 Non-opioid Pain Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock